Kennedy Capital Management LLC Has $11.35 Million Holdings in Mesa Laboratories, Inc. $MLAB

Kennedy Capital Management LLC lifted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 19.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 144,606 shares of the medical instruments supplier’s stock after acquiring an additional 23,060 shares during the period. Kennedy Capital Management LLC owned approximately 2.62% of Mesa Laboratories worth $11,352,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. Boston Partners grew its stake in shares of Mesa Laboratories by 86.6% in the fourth quarter. Boston Partners now owns 213,376 shares of the medical instruments supplier’s stock valued at $16,752,000 after acquiring an additional 99,019 shares in the last quarter. Simcoe Capital Management LLC acquired a new stake in Mesa Laboratories during the third quarter worth about $12,794,000. Royce & Associates LP grew its stake in Mesa Laboratories by 3.2% during the fourth quarter. Royce & Associates LP now owns 153,352 shares of the medical instruments supplier’s stock worth $12,038,000 after buying an additional 4,794 shares in the last quarter. Diamond Hill Capital Management Inc. grew its stake in Mesa Laboratories by 15.1% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 141,973 shares of the medical instruments supplier’s stock worth $11,145,000 after buying an additional 18,592 shares in the last quarter. Finally, Millennium Management LLC grew its stake in Mesa Laboratories by 131.9% during the third quarter. Millennium Management LLC now owns 133,817 shares of the medical instruments supplier’s stock worth $8,967,000 after buying an additional 76,107 shares in the last quarter. 90.60% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded shares of Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, June 3rd. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $94.00.

Mesa Laboratories Stock Performance

Shares of Mesa Laboratories stock opened at $105.48 on Monday. The company has a market capitalization of $582.25 million, a price-to-earnings ratio of 87.90 and a beta of 0.94. The company has a quick ratio of 1.29, a current ratio of 1.72 and a debt-to-equity ratio of 0.78. Mesa Laboratories, Inc. has a 12-month low of $55.45 and a 12-month high of $113.99. The firm’s 50-day moving average price is $101.45 and its two-hundred day moving average price is $90.24.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings data on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.78 by ($0.25). The firm had revenue of $63.72 million for the quarter, compared to analyst estimates of $65.21 million. Mesa Laboratories had a return on equity of 20.96% and a net margin of 2.69%.During the same quarter in the previous year, the company earned ($1.31) earnings per share.

Mesa Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Friday, May 29th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, May 29th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.6%. Mesa Laboratories’s dividend payout ratio is 53.33%.

Mesa Laboratories Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.